Association between ABCG2 rs2231142 and poor response to allopurinol: replication and meta-analysis (Q50000842)

23 February 2018

meta-analysis

0 references

title

Association between ABCG2 rs2231142 and poor response to allopurinol: replication and meta-analysis (English)

1 reference

23 February 2018

1 reference

5

Nicola Dalbeth

1 reference

23 February 2018

6

Ruth Topless

1 reference

23 February 2018

Tony Merriman

7

object named as

Tony R Merriman

1 reference

23 February 2018

Lisa Stamp

8

object named as

Lisa K Stamp

1 reference

23 February 2018

Rebecca Roberts

2

object named as

Rebecca L Roberts

1 reference

23 February 2018

author name string

Mary C Wallace

1

1 reference

23 February 2018

Payal Nanavati

3

1 reference

23 February 2018

Jeffrey N Miner

4

1 reference

23 February 2018

publication date

12 January 2018

1 reference

23 February 2018

published in

Rheumatology

1 reference

23 February 2018

2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia

cites work

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEX467

2016 updated EULAR evidence-based recommendations for the management of gout

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEX467

Genome-wide association study identifies ABCG2 (BCRP) as an allopurinol transporter and a determinant of drug response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEX467

ABCG2 loss-of-function polymorphism predicts poor response to allopurinol in patients with gout

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEX467

ABCG2 polymorphisms in gout: insights into disease susceptibility and treatment approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEX467

Identification of a urate transporter, ABCG2, with a common functional polymorphism causing gout

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEX467

Preliminary criteria for the classification of the acute arthritis of primary gout

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEX467

Illumina human exome genotyping array clustering and quality control

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEX467

Meta-analysis identifies multiple loci associated with kidney function-related traits in east Asian populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEX467

Association of functional polymorphism rs2231142 (Q141K) in the ABCG2 gene with serum uric acid and gout in 4 US populations: the PAGE Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEX467

Estrogen Enhances the Expression of the Multidrug Transporter Gene ABCG2-Increasing Drug Resistance of Breast Cancer Cells through Estrogen Receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEX467

Modulation of genetic associations with serum urate levels by body-mass-index in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEX467

Understanding the dose-response relationship of allopurinol: predicting the optimal dosage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEX467

Individualising the dose of allopurinol in patients with gout

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEX467

10.1093/RHEUMATOLOGY/KEX467

21 January 2018

Identifiers

DOI

1 reference

23 February 2018

1 reference

23 February 2018